What Is CL Fair Value?
Colgate-Palmolive Company (CL) fair value estimate using multiple valuation models, updated daily.
As of October 31, 2026, Colgate-Palmolive Company (CL) has a composite fair value estimate of $71.54 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $95.29, suggesting the stock is overvalued by 24.9%.
Data as of October 31, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$71.54
vs. current price of $95.29(-24.9%)
How Is CL Fair Value Calculated?
Four independent models estimate what CL is worth. Each uses different inputs and assumptions. The composite blends them by weight.
CL Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$127.07
+33.3%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$59.63
-37.4%Overvalued
Inputs used
CL Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$2.41
-97.5%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$38.67
-59.4%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $95.29 is 33.3% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $3.64B | $3.43B |
| Year 2 | $3.83B | $3.41B |
| Year 3 | $4.03B | $3.38B |
| Year 4 | $4.24B | $3.35B |
| Year 5 | $4.47B | $3.33B |
| Year 6 | $4.70B | $3.30B |
| Year 7 | $4.95B | $3.28B |
| Year 8 | $5.21B | $3.25B |
| Year 9 | $5.48B | $3.23B |
| Year 10 | $5.77B | $3.20B |
| Terminal Value | $166.33B | $92.41B |
What Are CL's Key Financial Metrics?
Earnings & Growth
Current Price
$95.29
EPS (TTM)
$2.54
Forward P/E
23.3
Profit Margin
9.7%
Cash & Balance Sheet
Free Cash Flow
3.5B
EBITDA
5B
Book Value
$0.07
Total Debt
7.9B
What Do Analysts Say About CL?
Low
$87.00
Average
$98.15
High
$110.00
Upside
+3.0%
CL Fair Value FAQ
What is the fair value of CL?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CL's estimated fair value is $71.54. The stock is currently trading at $95.29, which makes it overvalued by our analysis.
How is CL's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is CL overvalued or undervalued?
Based on our analysis, CL is overvalued. The current price of $95.29 is 24.9% above our estimated fair value of $71.54.
What do Wall Street analysts say about CL?
20 analysts cover Colgate-Palmolive Company with a consensus rating of "Buy." The average price target is $98.15, ranging from $87.00 to $110.00. This implies 3.0% upside from the current price.